CUSIP 74366E102COMPTGXQ4 2025
71 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 9.72M | $848.60M |
| 2 | Farallon Capital Management LLC | 6.14M | $536.62M |
| 3 | Vanguard Group Inc | 5.41M | $472.83M |
| 4 | Rtw Investments, LP | 5.06M | $441.86M |
| 5 | State Street Corp | 3.20M | $279.46M |
| 6 | Wellington Management Group LLP | 3.17M | $276.99M |
| 7 | Ubs Group AG | 2.77M | $241.93M |
| 8 | Janus Henderson Group PLC | 2.65M | $231.35M |
| 9 |
| 4 | Jan 30, 2026 | The Vanguard Group | 13G/A | 8.7% | 5.41M | SEC |
| 5 | Nov 14, 2025 | Deep Track Capital, LP | 13G/A | 2.8% | 1.72M | SEC |
| 6 | Nov 14, 2025 | Biotechnology Value Fund L P | 13G/A | 4.1% | 2.56M | SEC |
| 7 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 13.8% | 8.58M | SEC |
| 8 | Aug 11, 2025 | State Street Corporation | 13G | 5.2% | 3.21M | SEC |
| 9 | Jun 16, 2025 | Biotechnology Value Fund L P | 13G | 5.2% | 3.21M | SEC |
| 10 | May 13, 2025 | State Street Corporation | 13G | 4.4% | 2.71M | SEC |
See the full Schedule 13D/13G history for Protagonist Therapeutics Inc.
Unlock full history| 2.45M |
| $213.91M |
| 10 | Invesco Ltd. | 1.57M | $136.94M |